I am a researcher with an international reputation in economic evaluation and health technology assessment and have contributed significantly to the growth in the use of systematic reviews and economic modelling in this field. This expertise is built on nearly 30 years of health economics experience. I am currently a Professor of Health Economics which I joined in 2023. I am a member and health economics lead for the NICE funded Newcastle External Assessment Centre and lead health economist for the NIHR Behavioural Science Policy Research Unit. I am chair of the Executive of the NIHR research Support Service for the North East and North Cumbria,

Prior to joining LSHTM I led the Health Economics Group at Newcastle University. I was also Director of the NIHR funded Newcastle Technology Assessment Review Centre and collaborator and theme lead for the Enabling Methodologies Theme of the NIHR Applied Research Collaboration and collaborator and lead health economist on other NIHR infrastructure including the NIHR Newcastle In Vitro Diagnostics Co-operative, Patient Safety Research Collaboration and the Blood and Transplant research Unit .

Until 2023 I was co-ordinating editor of the NIHR funded Cochrane Incontinence Review Group and following reorganisation of Cochrane I remain as a sign-off editor. I was also Chair from 2010 to 2020 of the joint economic methods group of the international Cochrane and Campbell Collaborations (http://methods.cochrane.org/economics/) which develops the methods and conducts systematic reviews of interventions in health care and other policy areas; I am still actively developing methodology in this area.

I have considerable managerial and supervisory experience including most recently as the Deputy Director of the Institute of Health & Society at Newcastle University (until 2019). I also have a proven record in attracting research funds, completing projects to a high standard and in a timely fashion. I have extensive links with policy makers and researchers throughout the UK and internationally and was economic advisor the recent Topol review on digital medicine. The total value of competitive peer reviewed funding I have been awarded is in excess £165 million including a substantial number as Principal Investigator. In addition, I have a strong publication record with well over 400 papers in peer-reviewed journals, 4 books, 15 book chapters and over 100 other significant reports.